Catalyst Pharmaceuticals, Inc. (CPRX) insider trading.
In Q3 2026, insiders at Catalyst Pharmaceuticals, Inc. reported 13 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 13
- Last filed
- 2026-07-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Andrews William T. | Officer · Chief Medical Officer | 1 | 0 | 0 |
| Daly Richard J | Director, Officer · President and CEO | 1 | 0 | 0 |
| Del Carmen Jeffrey | Officer · Chief Commercial Officer | 1 | 0 | 0 |
| Denkhaus Donald A | Director | 1 | 0 | 0 |
| Elsbernd Brian | Officer · Chief Legal Officer | 1 | 0 | 0 |
| Harper Molly | Director | 1 | 0 | 0 |
| Kalb Michael Wayne | Officer · Chief Financial Officer | 1 | 0 | 0 |
| Mcenany Patrick J | Director, Other | 1 | 0 | 0 |
| Miller Steve | Officer · Chief Op. & Scientific Officer | 1 | 0 | 0 |
| Russo Gregg | Officer · Chief HR Officer | 1 | 0 | 0 |
| Sundaram Preethi | Officer · Chief Strategy Officer | 1 | 0 | 0 |
| Thompson Tamar | Director | 1 | 0 | 0 |
| Tierney David S | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Andrews William T. | D (D) | 2,309 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Daly Richard J | D (D) | 271,266 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | D (D) | 14,337 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Denkhaus Donald A | D (D) | 498,773 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Elsbernd Brian | D (D) | 242,501 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Harper Molly | D (D) | 3,694 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | D (D) | 13,665 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Mcenany Patrick J | D (D) | 4,171,559 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Miller Steve | D (D) | 1,093,803 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Russo Gregg | D (D) | 476 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | D (D) | 54,804 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Thompson Tamar | D (D) | 3,773 | $31.5 | 0 | Form 4 |
| 2026-07-15 | Tierney David S | D (D) | 383,314 | $31.5 | 0 | Form 4 |
Transaction codes in this quarter
Get CPRX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1369568&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · Catalyst Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Catalyst Pharmaceuticals, Inc. (CPRX)?
In Q3 2026, insiders at Catalyst Pharmaceuticals, Inc. reported 13 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Catalyst Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cprx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.